Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma
| Autor: | Pipas, J.M. *, Zaki, B.I., McGowan, M.M., Tsapakos, M.J., Ripple, G.H., Suriawinata, A.A., Tsongalis, G.J., Colacchio, T.A., Gordon, S.R., Sutton, J.E., Srivastava, A., Smith, K.D., Gardner, T.B., Korc, M., Davis, T.H., Preis, M., Tarczewski, S.M., MacKenzie, T.A., Barth, R.J., Jr |
|---|---|
| Zdroj: | In Annals of Oncology November 2012 23(11):2820-2827 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|